European Pharmaceutical Review

MARCH 5, 2024

International participation and trending topics With over 900 exhibitors, analytica 2024 promises an impressive lineup. The analytica conference addresses this topic with a session on the applications of AI algorithms in laboratory medicine. Top topics at the trade fair include digitalisation, Laboratory 4.0,

Consulting 93

Consulting Pharmaceutical Transportation Safety 93

Copyright Clearance Center

OCTOBER 3, 2023

trillion of value to the global economy annually, according to a report from McKinsey Global Institute published in June. CCC frequently convenes expert panels to explore complex and important topics in the world of research, publishing, and media. Generative AI is set to add up to $4.4

Training 118

Training Media Leads Marketing 118

Copyright Clearance Center

AUGUST 24, 2023

CCC brings a number of global FAIR and AI experts to this event, including: Barend Mons , President, CODATA; Erik Schultes , FAIR Implementation Lead, GO FAIR Foundation; Lars Juhl Jensen , Professor, NNF Center for Protein Research; Jane Lomax , Head of Ontologies, SciBite; and Martin Romacker , Product Manager, Roche Data Marketplace.

Management 97

Management Media Training Leads 97

Copyright Clearance Center

MARCH 5, 2024

The London Book Fair panel follows a series of Town Hall events on the topic of AI: “ The Heart of the Matter: Copyright, AI Training and LLMs ,” where experts discussed technical and legal aspects of the use of copyrighted content in AI systems. “

Training 98

Training Media Leads 98

Clarivate

FEBRUARY 3, 2022

As concerted global efforts towards these goals gain momentum, stakeholders across the research community need to find, assess and evaluate articles that directly align with the SDGs in order to understand how research outputs contribute to progress.

Ethics 98

Ethics Government Management 98

Clarivate

JANUARY 23, 2024

R&D productivity fell in 2022, but late-phase cancellations are also trending down The rise and fall of R&D productivity across the global biopharmaceutical industry is a well-documented and much discussed topic, with industry commentators quantifying productivity in many ways (e.g., Learn more about purchasing it here.

Pharma 52

Pharma Sales Consulting Pharmaceutical 52

pharmaphorum

NOVEMBER 11, 2022

Our CEO & Founder, Roberto Ascione , has been invited to close Day 2 of the virtual AHIMA22 Global Conference as a keynote speaker, November 11, 2022. The conference connects passionate health information professionals with the industry’s leading voices to cover the latest hot topics in healthcare.

Networking 52

Networking Healthcare Healthcare Leads 52

European Pharmaceutical Review

OCTOBER 13, 2022

The first focus will be to improve how work related to COVID-19 is handled: interactions with regulators, prioritising topics, managing medicines with no marketing authorisation, planning for HTAs and economic modelling methods. The bodies will work collectively on scientific and methodological topics to address these difficulties.

Distribution 89

Distribution Government Healthcare Healthcare 89

Pharmaceutical Technology

APRIL 19, 2023

Arcutis Biotherapeutics president and CEO Frank Watanabe stated: “The acceptance of the NDA for roflumilast foam marks a major milestone toward our goal of bringing a steroid-free, topical foam treatment option to market, addressing a significant unmet need for individuals living with seborrheic dermatitis. “If

Food and Drug Administration 52

Food and Drug Administration FDA Safety Prescription 52

European Pharmaceutical Review

AUGUST 3, 2022

The ideas and proposals put forward on this topic during the recent EDQM Symposium on Nanomedicines will be taken into account during the process, as will the experience gained with these vaccines during the COVID-19 pandemic, in which mRNA vaccines garnered regulatory approval for the first time.

Manufacturing 98

Manufacturing Government Safety Medicine 98

pharmaphorum

NOVEMBER 2, 2022

With pharmaphorum fully in attendance today, expect coverage of a wide range of topics, within a variety of formats, all united by a shared goal of seeking sustainable change for Britain, whilst bearing in mind her role upon the global stage at this critical juncture in history.

Pharma 83

Pharma Healthcare Healthcare Patients 83

Clarivate

MARCH 8, 2023

For this study, we also included a search for “health equity” in our global database of dissertations and theses. Exploring dissertations allows us insights into the topics researched by graduate students around the world. Figure 1: Recurring keywords in research on health equity and women. Created by wordcloud.com.

Healthcare 98

Healthcare Healthcare Specialization Patients 98

pharmaphorum

OCTOBER 6, 2022

The new version – dubbed Florence 2.0 – covers a broader range of topics. The topics chosen for Florence are some of those that have the greatest burden on health around the world, and according to her developers she could help support healthcare workers in areas where there are shortages in healthcare staff.

Healthcare 136

Healthcare Healthcare Leads Patients 136

KBK Communications

NOVEMBER 10, 2022

Digital Transformation has become a hot topic globally for good reason!

Marketing 40

Marketing 40

European Pharmaceutical Review

MARCH 7, 2023

It will be made up of 13 leaders from large global pharmaceutical companies. I joined the Pistoia Alliance because I see global collaboration as the key to unlocking the life science industry’s expertise.” The Pistoia Alliance has launched its Pharma Innovation Council.

Pharma 70

Pharma Consulting Leads Competition 70

pharmaphorum

SEPTEMBER 28, 2022

Co-chairs Di Morris, Clinical Auditor, AstraZeneca and Nigel Cryer, Deputy Director Global Audit, Sanofi. Sponsored by: Microgenetics. Harnessing Alternative Rapid Microbial Methods for a Successful Contamination Control Strategy.

Pharmaceutical 52

Pharmaceutical Management 52

pharmaphorum

DECEMBER 2, 2022

A new global prostate cancer awareness campaign developed by biopharmaceutical companies AstraZeneca (AZ) and Merck & Co. Prostate cancer is the second most common cancer in men globally, and it affects millions of people around the world indirectly. Never miss a goal. Never miss a chance at early diagnosis. In 2020, there were 1.4

Media 72

Media Physicians Patients Medical 72

pharmaphorum

OCTOBER 18, 2022

Oculis SA, a global biopharmaceutical company that develops treatments for saving sight and improving eye care with breakthrough innovations, is to combine with the European Biotech Acquisition Corp (EBAC), a special purpose acquisition company (SPAC) that has screened over 100 European biotechnology companies.

Biopharma 59

Biopharma Management Specialization Physicians 59

pharmaphorum

OCTOBER 12, 2022

Speakers Include: Sebastian Stening, Vice President and Global Head Medical Device Manufacturing Science and Technology, Bayer. Claus Geiger, Global Medical Device Leader, Sanofi. Murray Sayce, Global Head, Sustainability Assurance, BSI Group. Mitali Aon, VP and Global Head of Device Development, Sanofi.

Engineering 52

Engineering Safety Consulting Medical 52

European Pharmaceutical Review

JANUARY 31, 2023

Across Part A and Part B , of which the approval was based on, 74 percent of patients were previously treated with swallowed topical corticosteroids. More than 500,000 patients have been treated with Dupixent globally. Dupilumab is being jointly developed by Sanofi and Regeneron under a global collaboration agreement.

Medicine 93

Medicine Safety Patients Pharmaceutical 93

Clarivate

JULY 24, 2023

BioNTainer features modular production units, GMP-compliant setup and personnel training, with each unit designed to function as a regional node in a global manufacturing network for rapid response to infectious disease outbreaks. Incyte also notches two mentions, first for the U.S.-based

Pharma 52

Pharma Biopharma Prospecting Training 52

World of DTC Marketing

MAY 7, 2021

Though Facebook does not offer advertisers categories that explicitly identify people’s health conditions, The Markup identified dozens of ads for prescription pharmaceuticals targeted at people with “interests” in topics like “bourbon,” “oxygen,” and “Diabetes mellitus awareness.”.

Media 283

Media Prescription Pharma Consulting 283

Pharmaceutical Technology

MAY 10, 2023

While the government said that Gilead secured its PrEP approvals only after CDC’s research on the topic, the company stated that there already were published materials on the potential use of antiretroviral therapies as PrEP prior to this. billion in global sales in 2029, while Truvada estimates amount to $30 million.

Government 105

Government FDA Pharmaceutical Pharma 105

Clarivate

SEPTEMBER 27, 2022

While significant developments have been made to improve sustainable water and sanitation services over recent years, climate change is presenting new and global challenges that are exacerbating the water crisis. The global perspective he and his coauthors employ highlights the intricate connectivity of our water supply across the planet.

Management 98

Management Government Pharmaceutical Networking 98

Pharmaceutical Technology

FEBRUARY 13, 2023

This trial assessed Cibinqo 100mg and 200mg doses against placebo in moderate-to-severe AD adolescents aged 12 to less than 18 years who were on background treatment with topical medications.

Food and Drug Administration 59

Food and Drug Administration FDA Food Medicine 59

Clarivate

DECEMBER 15, 2022

As we say goodbye to 2022 and look forward to the year ahead, it is a great opportunity to reflect on the topics we covered in our blog series on IP lifecycle management. Clarivate received special recognition in Hyperion Global Partners’ 2022 MarketView Report for IP Management Systems for Law Firms and Corporations.

Management 52

Management Transportation Specialization Consulting 52

pharmaphorum

NOVEMBER 28, 2022

Stuart Cooper admitted that attending Anthropy was in itself for the purpose of learning, of understanding what healthcare and biopharma can do with regards to improving its place in the global, as much as the British, plan and bettering people’s lives; that is, beyond tablets and sickness maintenance. Then, we discuss the topic of ESG.

Pharma 93

Pharma Biopharma Recruitment Management 93

Pharmaceutical Technology

FEBRUARY 9, 2023

ReviR Therapeutics chief scientific officer Paul August said: “Asieris is a global biopharma company specialised in the development of GU oncology therapies, and we are excited to be working with them to discover new treatments for indications of interests. “We Topic sponsors are not involved in the creation of editorial content.

Biopharma 96

Biopharma Pharmaceutical Patients Marketing 96

pharmaphorum

OCTOBER 31, 2022

Founded in 2021 by John O’Brien (as a result of concerns for the economic and social impacts of COVID-19 and negative public discourse borne from Brexit), Anthropy seeks to set aside any organisational divisions and focus on a united and ameliorated vision of Britain and its place within the global whole.

Pharma 85

Pharma Pharmaceutical Patients 85

Pharmaceutical Technology

JULY 12, 2022

The Roflumilast cream is a once-a-day topical formulation of the selective phosphodiesterase type 4 (PDE4) inhibitor, roflumilast. In DERMIS-1 and DERMIS-2 trials, roflumilast had an Investigator Global Assessment (IGA) success rate of 42.4% A validated target in dermatology, PDE4 is an enzyme that induces overactive immune responses.

Food and Drug Administration 64

Food and Drug Administration Safety Food Pharmaceutical 64

Pharmaceutical Technology

OCTOBER 19, 2022

It has combined expertise in otology, gene therapy and inner ear drug delivery to meet the requirements of individuals with disabling hearing loss globally. Topic sponsors are not involved in the creation of editorial content. AK-OTOF is the lead product candidate of the company.

Pharmaceutical 119

Pharmaceutical Medicine Leads Medical 119

pharmaphorum

NOVEMBER 1, 2022

This is reflected with the value of the global antisense & RNA therapeutics market expected to reach USD 1.81 Further topics to be examined comprise of novel RNA modalities encompassing self-amplifying RNA, saRNA, circular RNA, lnc RNA and many more. Global Heads of mRNA R&D. Global Medical Directors.

Pharmacology 52

Pharmacology Medicine Networking Pharma 52

Pharmaceutical Technology

FEBRUARY 8, 2023

AGC Biologics is a global biopharmaceutical contract development and manufacturing organisation (CDMO). It provides end-to-end global cell therapy and viral vector development, production, and quality/regulatory services. Topic sponsors are not involved in the creation of editorial content.

Manufacturing 52

Manufacturing Pharmaceutical Medicine Management 52

Pharmaceutical Technology

SEPTEMBER 12, 2022

The percentage of subjects attaining Psoriasis Area and Severity Index (PASI) 75 as well as static Physician’s Global Assessment score of 0 or 1 (sPGA 0/1) at week 16 compared to placebo were the co-primary endpoints of the trials.

Food and Drug Administration 98

Food and Drug Administration FDA Food Safety 98

Pharmaceutical Technology

MARCH 30, 2023

The topical and oral form of the compound is intended to treat glaucoma and dry age-related macular degeneration (AMD), as well as other ophthalmic indications with high unmet medical need, in Africa, the Middle East, the Americas and Europe.

Sales 52

Sales Medical Patients 52

Pharmaceutical Technology

MARCH 31, 2023

Topic sponsors are not involved in the creation of editorial content. The new facility is expected to enable the manufacturing of drug products for Kenya and Africa, and will be able to quickly scale up its production and respond to public health emergencies on the continent and worldwide.

Manufacturing 105

Manufacturing Government Medicine Healthcare 105

Pharmaceutical Technology

APRIL 27, 2023

With multi-product, in-house viral vector production capabilities, the new facility in Libertyville, Illinois, US, is expected to strengthen the company’s long-term viral vector supply and advance its long-term goals and global manufacturing network in cell therapy. Topic sponsors are not involved in the creation of editorial content.

Engineering 52

Engineering Manufacturing Networking Medicine 52